RE: Care to comment Ahfam26 Jun 2023 19:50
Hi Benhowell
I think Doolinator gave a pretty sound response to your query, there are many aspects to the granting of patents and their specific "quality" in their field of play, the approach of capsule formulation as an example, if as suggested one patent covered the whole aspect of an approach to drug development we wouldn't have so many pharmas chasing the Tyck/JAK process - we keep nibbling and protecting what we have.
Just my take on it and given John Reader's assertion it gives as protection to our progressing IP as a drug development Company, I'm happy with that - of course I appreciate others will play on the query you have genuinely raised, but, it's as C79 alluded to, attention to detail that counts.
GLA